F2 and COVID-19: Among COVID-19 patients, particularly those requiring intensive care admission, laboratory findings of low lymphocyte count, elevated levels of cardiac troponin, interleukins, and procoagulant factors (prolonged prothrombin time and high D-dimer levels) have been found, which further buttresses a plausible link between COVID-19 and ACS [5,7,11].